BMC cardiovascular disorders

· 6 papers in corpus
2025
doi:10.1186/s12872-025-05255-w ·PMID:41204186

BackgroundCardioneuroablation (CNA) is increasingly used worldwide in the treatment of functional bradyarrhythmia mediated by excessive vagal tone. However, a potential early or long-term complication is the development of postprocedural in…

2025
doi:10.1186/s12872-025-05141-5 ·PMID:40877791

IntroductionCarbohydrate Antigen 125 (CA125) has emerged as a potential biomarker in patients with heart failure (HF). This meta-analysis comprehensively evaluates the association between CA125 levels and clinical outcomes across HF populat…

2025
doi:10.1186/s12872-025-05260-z ·PMID:41162864

Background and aimsChronic heart failure (HF) is often linked to increased oxidative stress and metabolic issues like high uric acid, which can worsen outcomes. Astaxanthin (ASX), a strong antioxidant, may help reduce these harmful effects.…

2024
doi:10.1186/s12872-024-04180-8 ·PMID:39304821

BackgroundWomen with pre-existing cardiac conditions who undergo assisted reproductive technologies (ART) are believed to be at a heightened risk of cardiovascular events during both the treatment and pregnancy phases. An unresolved questio…

2022
doi:10.1186/s12872-022-03032-7 ·PMID:36587199

BackgroundThis study is designed to compare the menstrual blood stem cells (MenSCs) and bone marrow stem cells (BMSCs)-secreted factors with or without pre-treatment regimen using basic fibroblast growth factor (bFGF) and 5-aza-2'-deoxycyti…

2020
doi:10.1186/s12872-020-01372-w ·PMID:32028900

BackgroundTobacco smoke is one of the most significant risk factors for cardiovascular diseases and damages in the myocardial tissue directly. Cardiac magnetic resonance (CMR) has been used and is a promising tool to evaluate morphometry an…